IP Verse

Alnylam Pharmaceuticals Inc. opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Further Novel Forms Of Interfering Rna Molecules

Applicant:

Opposition Date:

Oct 31, 2018

Patent Number:

Title:

Futher Novel Forms Of Interfering Rna Molecules

Applicant:

Opposition Date:

Oct 19, 2017

Patent Number	Title	Applicant	Opposition Date
EP3222724	Further Novel Forms Of Interfering Rna Molecules	SILENCE THERAPEUTICS GMBH	Oct 31, 2018
EP2258847	Futher Novel Forms Of Interfering Rna Molecules	SILENCE THERAPEUTICS AG	Oct 19, 2017

SILENCE THERAPEUTICS GMBH

SILENCE THERAPEUTICS AG

Feel free to send us a message here and we will get back to you